Sentence: To evaluate the efficacy and safety of lapatinib ( L ) and trastuzumab ( T ) combination in HER2-positive metastatic breast cancer ( MBC ) patients previously treated with T and/or L.
Drug combination annotation:
[{'class': 'POS', 'spans': ['lapatinib', 'trastuzumab'], 'is_context_needed': True}]